Search research articles
Contact Us
Filters
Showing results (31-40 of 63) with videos related to
Page
of 7
Sort By:
Journal of Clinical Lipidology
|
February 10, 2024
Efficacy and safety of bempedoic acid in patients with heterozygous familial hypercholesterolemia: analysis of pooled patient-level data from phase 3 clinical trials
P Barton Duell, Maciej Banach, Alberico L Catapano, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium
|
November 13, 2008
Improving adherence to dyslipidemia medication guidelines in hospitalized diabetic patients using a technology-assisted pharmacist intervention
Peggy S McKinnon, Terry Seaton, Laura A Noirot, et al.
JAMA Cardiology
|
November 13, 2018
Influence of Cardiovascular Risk Communication Tools and Presentation Formats on Patient Perceptions and Preferences
Ann Marie Navar, Tracy Y Wang, Xiaojuan Mi, et al.
Journal of Clinical Lipidology
|
September 26, 2020
A retrospective analysis of clinical use of alirocumab in lipoprotein apheresis patients
Anne C Goldberg, Richard L Dunbar, Linda Hemphill, et al.
Clinical Cardiology
|
May 19, 2021
Patient perceptions and use of non-statin lipid lowering therapy among patients with or at risk for atherosclerotic cardiovascular disease: Insights from the PALM registry
Angela Lowenstern, Shuang Li, Ann Marie Navar, et al.
European Journal of Preventive Cardiology
|
July 31, 2019
Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy
Christie M Ballantyne, Ulrich Laufs, Kausik K Ray, et al.
Journal of the American Heart Association
|
August 25, 2021
Racial Disparities in Modifiable Risk Factors and Statin Usage in Black Patients With Familial Hypercholesterolemia
Anandita Agarwala, Nathan Bekele, Elena Deych, et al.
Journal of Clinical Lipidology
|
February 5, 2011
Efficacy and safety of fenofibric acid in combination with a statin in patients with mixed dyslipidemia: Pooled analysis of three phase 3, 12-week randomized, controlled studies
Peter H Jones, Michael H Davidson, Anne C Goldberg, et al.
JAMA
|
November 13, 2019
Effect of Bempedoic Acid vs Placebo Added to Maximally Tolerated Statins on Low-Density Lipoprotein Cholesterol in Patients at High Risk for Cardiovascular Disease: The CLEAR Wisdom Randomized Clinical Trial
Anne C Goldberg, Lawrence A Leiter, Erik S G Stroes, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium
|
January 24, 2007
Improving adherence to coronary heart disease secondary prevention medication guidelines at a community hospital
Thomas C Bailey, Laura A Noirot, Brian F Gage, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 63) with videos related to
Sort By:
Page
of 7
Journal of Clinical Lipidology
|
February 10, 2024
Efficacy and safety of bempedoic acid in patients with heterozygous familial hypercholesterolemia: analysis of pooled patient-level data from phase 3 clinical trials
P Barton Duell, Maciej Banach, Alberico L Catapano, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium
|
November 13, 2008
Improving adherence to dyslipidemia medication guidelines in hospitalized diabetic patients using a technology-assisted pharmacist intervention
Peggy S McKinnon, Terry Seaton, Laura A Noirot, et al.
JAMA Cardiology
|
November 13, 2018
Influence of Cardiovascular Risk Communication Tools and Presentation Formats on Patient Perceptions and Preferences
Ann Marie Navar, Tracy Y Wang, Xiaojuan Mi, et al.
Journal of Clinical Lipidology
|
September 26, 2020
A retrospective analysis of clinical use of alirocumab in lipoprotein apheresis patients
Anne C Goldberg, Richard L Dunbar, Linda Hemphill, et al.
Clinical Cardiology
|
May 19, 2021
Patient perceptions and use of non-statin lipid lowering therapy among patients with or at risk for atherosclerotic cardiovascular disease: Insights from the PALM registry
Angela Lowenstern, Shuang Li, Ann Marie Navar, et al.
European Journal of Preventive Cardiology
|
July 31, 2019
Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy
Christie M Ballantyne, Ulrich Laufs, Kausik K Ray, et al.
Journal of the American Heart Association
|
August 25, 2021
Racial Disparities in Modifiable Risk Factors and Statin Usage in Black Patients With Familial Hypercholesterolemia
Anandita Agarwala, Nathan Bekele, Elena Deych, et al.
Journal of Clinical Lipidology
|
February 5, 2011
Efficacy and safety of fenofibric acid in combination with a statin in patients with mixed dyslipidemia: Pooled analysis of three phase 3, 12-week randomized, controlled studies
Peter H Jones, Michael H Davidson, Anne C Goldberg, et al.
JAMA
|
November 13, 2019
Effect of Bempedoic Acid vs Placebo Added to Maximally Tolerated Statins on Low-Density Lipoprotein Cholesterol in Patients at High Risk for Cardiovascular Disease: The CLEAR Wisdom Randomized Clinical Trial
Anne C Goldberg, Lawrence A Leiter, Erik S G Stroes, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium
|
January 24, 2007
Improving adherence to coronary heart disease secondary prevention medication guidelines at a community hospital
Thomas C Bailey, Laura A Noirot, Brian F Gage, et al.
Page
of 7